Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3249170
Max Phase: Preclinical
Molecular Formula: C25H37ClN2O
Molecular Weight: 362.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3249170
Max Phase: Preclinical
Molecular Formula: C25H37ClN2O
Molecular Weight: 362.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCN(CC)CCCN1CC[C@H]2c3ccccc3[C@@H](c3ccccc3)[C@H]2C1.Cl.O
Standard InChI: InChI=1S/C25H34N2.ClH.H2O/c1-3-26(4-2)16-10-17-27-18-15-22-21-13-8-9-14-23(21)25(24(22)19-27)20-11-6-5-7-12-20;;/h5-9,11-14,22,24-25H,3-4,10,15-19H2,1-2H3;1H;1H2/t22-,24-,25+;;/m0../s1
Standard InChI Key: PATBNDYZGCHQOO-ONRUCFPPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 362.56 | Molecular Weight (Monoisotopic): 362.2722 | AlogP: 4.97 | #Rotatable Bonds: 7 |
Polar Surface Area: 6.48 | Molecular Species: BASE | HBA: 2 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.33 | CX LogP: 4.64 | CX LogD: 1.25 |
Aromatic Rings: 2 | Heavy Atoms: 27 | QED Weighted: 0.69 | Np Likeness Score: -0.58 |
1. Ellefson CR, Woo CM, Cusic JW.. (1978) Synthesis and antiarrhythmic activity of 2-dialkylaminoalkyl-9-phenyl-1H-indeno[2,1-c]pyridine derivatives., 21 (4): [PMID:650662] [10.1021/jm00202a005] |
Source(1):